Repligen corporation
Health-Care > Biotechnology:-Biological-Products-(No-Diagnostic-Substances)
RGEN
Links
Price
- Last Close
-
$ 149.94
4.85 %
+6.93
Jan 3, 2025
- Trading Volume
- 20,017
- 52-Week High/Low
- $208 - $114
- Market Cap Full
- $ 8.4B
- YTD
- -100%
Returns +
Q
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 4.1% | 2% | -0.6% | -29% | 1.5% | -5% | 12% | -0.3% | 14.2% | - |
| Q2 | - | - | -30.9% | -16% | -13.7% | 2.7% | 4% | 43% | 33.3% | 17.7% | - |
| Q3 | - | - | -10% | 12.4% | 15.2% | 46.1% | 8% | -9.6% | 18% | -7.5% | - |
| Q4 | - | - | -6.9% | 16% | -9.5% | -9.2% | 28.4% | 19.3% | -5% | -3.6% | - |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | 4.1% | - | - | - | - | - | - | - | - | - | - | - |
Returns +
A
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RGEN | -100% | 4% | -20% | 6% | -36% | 38% | 107% | 76% | 45% | 18% | 9% |
Earnings
| id | company_name | ticker | sector | industry | addresss | state | city | zip | country | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | ||||||||||
| Q2 | ||||||||||
| Q3 | ||||||||||
| Q4 | ||||||||||
| A |